Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 23Lung Neoplasms 12Prostatic Neoplasms 10Squamous Cell Carcinoma of Head and Neck 8Breast Neoplasms 5Stomach Neoplasms 4Prostatic Neoplasms, Castration-Resistant 4Neoplasms 4Neoplasm Metastasis 3Endometrial Neoplasms 3Carcinoma, Transitional Cell 3Carcinoma 3Urinary Bladder Neoplasms 2Triple Negative Breast Neoplasms 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Oropharyngeal Neoplasms 2Nasopharyngeal Carcinoma 2Melanoma 2Lymphoid Interstitial Pneumonia 2Head and Neck Neoplasms 2HER2-positive Breast Cancer 2Esophageal Neoplasms 2Anatomic Stage I Breast Cancer AJCC v8 2Vaccinia 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urothelial Cancer 1Tongue Neoplasms 1Stage I Prostate Adenocarcinoma AJCC v7 1Solid Tumors 1

Interventions

Radiotherapy, Conformal 2Radiotherapy 2Paclitaxel 2Carboplatin 2veliparib 1pegylated granulocyte colony-stimulating factor 1pegfilgrastim 1Taxes 1Specimen Handling 1Radiotherapy, Intensity-Modulated 1Radiation 1Platinum 1Nivolumab 1Metformin 1Magnetic Resonance Spectroscopy 1Ipilimumab 1Immunoglobulin G 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Etoposide 1Docetaxel 1Disulfides 1Cisplatin 1CTLA-4 Antigen 1Bevacizumab 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Adenocarcinoma, Bronchiolo-Alveolar × Docetaxel × 30 days × Clear all
NCT00334815 2026-05-26

Combination Chemotherapy, Radiation Therapy, and Bevacizumab in Treating Patients With Newly Diagnosed Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery

National Cancer Institute (NCI)

Phase 2 Active not recruiting
29 enrolled 10 charts
Thoracic

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar

Data powered by HemOnc (CC BY 4.0) Colophon âš¡